[1]
A. Ferraris, “Antipsychotic use, immunomodulation and increased risk of bloodstream infections”, Rev Hosp Ital B.Aires, vol. 41, no. 2, pp. 84–85, Jun. 2021, doi: 10.51987/revhospitalbaires.v41i2.93.